APA

Tolppanen A., Taipale H., Koponen M., Tanskanen A., Lavikainen P., Paananen J., Tiihonen J. & Hartikainen S. (20180430). Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. : Pharmacoepidemiology and drug safety.

Chicago

Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Paananen Jussi, Tiihonen Jari and Hartikainen Sirpa. 20180430. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. : Pharmacoepidemiology and drug safety.

Harvard

Tolppanen A., Taipale H., Koponen M., Tanskanen A., Lavikainen P., Paananen J., Tiihonen J. and Hartikainen S. (20180430). Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. : Pharmacoepidemiology and drug safety.

MLA

Tolppanen Anna-Maija, Taipale Heidi, Koponen Marjaana, Tanskanen Antti, Lavikainen Piia, Paananen Jussi, Tiihonen Jari and Hartikainen Sirpa. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. : Pharmacoepidemiology and drug safety. 20180430.